Sebastian Stintzing

Has grant

Professor

Charité - Universitätsmedizin Berlin

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Cancer Biology Cancer Biology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Biomarker in metastatic colorectal cancer

Open Date: 2012-01-01

Close Date: 2014-01-01

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (10)

Uwe Pelzer

GERMANY

View details

Gunnar Folprecht

University Hospital Carl Gustav Carus

GERMANY

View details

Dominik Geisel

Charité

GERMANY

View details

Andreas Bender

Postdoctoral Lecturer and Research Associate

Ludwig-Maximilians-Universität München

GERMANY

View details

david tougeron

FRANCE

View details

C. Benedikt Westphalen

GERMANY

View details

Peter Horak

Deputy Head of Department

UniversitätsKlinikum Heidelberg

GERMANY

View details

Gabriele Pecher

Charité - Universitätsmedizin Berlin

GERMANY

View details

Günther Schönrich

Professor

Charité - Universitätsmedizin Berlin

GERMANY

View details

Manuela Benary

Charité - Universitätsmedizin Berlin

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sebastian Stintzing

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

The Oncology Biomarker Discovery framework reveals cetuximab and bevacizumab response patterns in metastatic colorectal cancer

FOLFOXIRI Plus Cetuximab or Bevacizumab as First-Line Treatment of BRAFV600E-Mutant Metastatic Colorectal Cancer: The Randomized Phase II FIRE-4.5 (AIO KRK0116) Study

Tumour mutational burden and survival with molecularly matched therapy

Impact of Smoking, Body Weight, Diabetes, Hypertension and Kidney Dysfunction on Survival in Pancreatic Cancer Patients—A Single Center Analysis of 2323 Patients within the Last Decade

Next Generation CD44v6-Specific CAR-NK Cells Effective against Triple Negative Breast Cancer

Inflammation-Based Prognostic Scores in Pancreatic Cancer Patients—A Single-Center Analysis of 1294 Patients within the Last Decade

Geriatric assessment and the variance of treatment recommendations in geriatric patients with gastrointestinal cancer-a study in AIO oncologists.

Impact of sex on the efficacy and safety of panitumumab plus fluorouracil and folinic acid versus fluorouracil and folinic acid alone as maintenance therapy in RAS WT metastatic colorectal cancer (mCRC). Subgroup analysis of the PanaMa-study (AIO-KRK-0212).

Key Prognostic Factors Create a Composite Risk Score to Stratify Patients into High- and Low-Treatment Benefit Groups: A Multicenter, Retrospective Data Analysis of 84 Metastatic Colorectal Cancer Patients Treated with Regorafenib as Part of the CORRECT and CONSIGN Trials

EMT-Related Genes Have No Prognostic Relevance in Metastatic Colorectal Cancer as Opposed to Stage II/III: Analysis of the Randomised, Phase III Trial FIRE-3 (AIO KRK 0306; FIRE-3)

Collaborators (10)

Uwe Pelzer

Gunnar Folprecht

Dominik Geisel

Andreas Bender

david tougeron

C. Benedikt Westphalen

Peter Horak

Gabriele Pecher

Günther Schönrich

Manuela Benary

Make your next move.